e-learning
resources
Glasgow 2004
Sunday 05.09.2004
Improved understanding of the basic mechanisms impact on the management of COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The influence of smoking on COPD phenotypes
J. C. Ratoff, M. W. Lethbridge, T. Snape, H. W. Wong, C. J. Corrigan, B. J. O‘Connor (London, United Kingdom)
Source:
Annual Congress 2004 - Improved understanding of the basic mechanisms impact on the management of COPD
Session:
Improved understanding of the basic mechanisms impact on the management of COPD
Session type:
Oral Presentation
Number:
262
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. C. Ratoff, M. W. Lethbridge, T. Snape, H. W. Wong, C. J. Corrigan, B. J. O‘Connor (London, United Kingdom). The influence of smoking on COPD phenotypes. Eur Respir J 2004; 24: Suppl. 48, 262
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
The influence of smoking on hydrolipoperoxidation in COPD patients
Source: Eur Respir J 2003; 22: Suppl. 45, 306s
Year: 2003
The tobacco smoking influence on parodontic inflammation in patients with COPD
Source: Eur Respir J 2007; 30: Suppl. 51, 167s
Year: 2007
Influence of smoking intensity and smoking quitting on lung function parameters in COPD patients
Source: Annual Congress 2011 - Smoking cessation science and smoking-related disorders
Year: 2011
COPD: causal factors other than active smoking
Source: Annual Congress 2006 - PG3 - Update on occupational and environmental lung disease, including "bring your own cases" for interactive discussion
Year: 2006
The effect of bupropion on smoking cessation and sleep physiology in COPD and asthma patients
Source: International Congress 2018 – Tobacco use and cessation interventions in patients with respiratory, cardiovascular and mental health problems and other populations
Year: 2018
The influence of smoking on the treatment response in patients with asthma
Source: Annual Congress 2007 - PG15 - Difficult-to-treat asthma: dealing with smoker patients
Year: 2007
COPD patients‘ response to smoking cessation
Source: Annual Congress 2005 - Smoking cessation in respiratory diseases: methods and results
Year: 2005
COPD non-exacerbator phenotype is associated with current smoking but not with Haptoglobin phenotype
Source: International Congress 2017 – Airway disease and exacerbations
Year: 2017
Effect of smoking on lung functions in patients with COPD
Source: Eur Respir J 2005; 26: Suppl. 49, 157s
Year: 2005
The ability of the eNose on the discrimination of smoking status in asthma and COPD
Source: Virtual Congress 2020 – Exhaled biomarkers of asthma and the asthma burden
Year: 2020
Effects of smoking cessation in COPD
Source: Annual Congress 2006 - Smoking and COPD: will it ever vanish into smoke?
Year: 2006
Do childhood factors and asthma modify the impact of smoking on COPD?
Source: Annual Congress 2010 - Risk factors for asthma in children and adults including severe disease
Year: 2010
The effect of smoking on the activity of inflammatory markers in patients with COPD
Source: Annual Congress 2013 –Tobacco use in different countries: crisis to disease
Year: 2013
Comorbidities by smokers with COPD and influence of risk factors
Source: Annual Congress 2010 - Smoking related disorders
Year: 2010
Impact of polymorphisms in genes involved in nicotine dependence pathways on the smoking burden of COPD patients
Source: International Congress 2019 – New molecular signatures in COPD, lung cancer and a1-antitrypsin deficiency
Year: 2019
The impact of smoking cessation on respiratory symptoms in patients with COPD
Source: Eur Respir J 2005; 26: Suppl. 49, 391s
Year: 2005
The impact of smoking on the platelets functional activity in patients with COPD
Source: International Congress 2017 – COPD biomarkers
Year: 2017
Smoking habit and psychological status in patients with asthma
Source: Annual Congress 2006 - Smoking asthmatics – a neglected population?
Year: 2006
The effect of smoking on lung function: a clinical study of adult-onset asthma
Source: Eur Respir J 2016; 48: 1298-1306
Year: 2016
Associations between passive smoking in childhood and COPD among adult smokers
Source: Annual Congress 2009 - Risk factors for COPD
Year: 2009
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept